false
0001864531
0001864531
2024-12-06
2024-12-06
0001864531
us-gaap:CommonStockMember
2024-12-06
2024-12-06
0001864531
us-gaap:WarrantMember
2024-12-06
2024-12-06
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
December 6, 2024
VSEE
HEALTH, INC.
(Exact name of registrant as specified in its charter)
Delaware |
|
001-41015 |
|
86-2970927 |
(State or other jurisdiction of incorporation) |
|
(Commission
File Number) |
|
(I.R.S. Employer Identification No.) |
980 N Federal Hwy #304
Boca Raton, Florida |
|
33432 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (561) 672-7068
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class |
|
Trading
Symbol |
|
Name of each exchange
on
which registered |
Common Stock, $0.0001 par value per share |
|
VSEE |
|
The Nasdaq Stock Market LLC |
Warrants,
which entitles the holder to purchase one (1) share of common stock at a price of $11.50 per whole share |
|
VSEEW |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company x
If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 7.01. Regulation FD Disclosure.
On December 6, 2024, VSee Health, Inc.
(the “Company”) issued a press release announcing a strategic partnership with AbundaBox to launch AbundaLife™, a health
record management platform. A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference.
The information included in this Item 7.01
and Exhibit 99.1 of this Current Report on Form 8-K is not deemed to be “filed” for purposes of Section 18
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section,
nor shall this item and Exhibit 99.1 be incorporated by reference into the Company’s filings under the Securities Act of 1933,
as amended, or the Exchange Act, except as expressly set forth by specific reference in such future filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits:
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned
hereunto duly authorized.
Dated: December 11, 2024 |
VSEE HEALTH, INC. |
|
|
|
|
By: |
/s/ Imoigele
Aisiku |
|
Name: |
Imoigele Aisiku |
|
Title: |
Co-Chief Executive Officer |
Exhibit 99.1
VSee Health Partners with AbundaBox to Launch
AbundaLife™: Transforming Health Record Management for Families Nationwide
SAN JOSE, Calif. -- December 6, 2024 -- VSee
Health, Inc. (Nasdaq: VSEE), a leader in telehealth solutions renowned for its scalable technology and deep clinical expertise, announced
a strategic partnership with AbundaBox to launch AbundaLife™, a groundbreaking health record management platform. This innovative
solution addresses one of the most pressing challenges in healthcare-fragmented medical records-by consolidating personal health data
into one secure, comprehensive profile. AbundaLife, supported by VSee Health's dynamic technology, empowers individuals to manage their
health more effectively, enabling providers to deliver better-coordinated care and improving health outcomes.
"VSee Health's commitment to improving access
and equity in healthcare aligns perfectly with AbundaBox's mission of empowering individuals through innovation," said Imo Aisiku,
Co-CEO and Chairman of VSee Health. "Together, with AbundaLife, we're addressing inefficiencies in healthcare management and enhancing
the patient experience like never before. At just $34 per year per patient, this partnership has already attracted eight healthcare facilities
in its initial rollout, demonstrating the immense potential for revenue acceleration and broad market adoption."
Expanding Access to Care
AbundaLife simplifies healthcare by centralizing
a lifetime of medical data-including medical records, lab results, prescriptions, immunizations, and more-into a single, easily accessible
profile. For patients, this streamlined solution provides:
| · | Improved Care Coordination: Unified access to health data minimizes communication delays and reduces
errors, helping providers make better-informed decisions. |
| · | Personalized Treatment: A complete health history empowers clinicians to develop tailored care
plans for superior health outcomes. |
| · | Simplified Health Management: With one secure platform, members can efficiently manage their medical
journey without the burden of navigating multiple systems. |
Innovative Collaboration, Real Impact
Built on VSee Health's state-of-the-art AI telehealth
technology, AbundaLife integrates seamless telehealth support, clinical reviews, and billing services. Emily Jones, CEO of Abundabox,
notes the transformative nature of the partnership, stating, "By combining VSee Health's scalable technology with AbundaBox's commitment
to health equity, AbundaLife is poised to bridge critical gaps in healthcare access and empower individuals to lead healthier lives."
A Mission-Driven Partnership
AbundaBox, renowned for its leadership in integrated
health solutions, brings deep expertise in addressing social determinants of health. Their expansive network and resource management capabilities
align with VSee Health's vision of leveraging technology to improve access, affordability, and quality of care for all.
About VSee Health
VSee Health is a leading provider of telehealth
solutions, specializing in real-time virtual care, clinical review, and billing services. Its technology powers healthcare networks and
organizations worldwide, enabling seamless patient-provider interactions and ensuring efficient care delivery. Field-hardened on over
1.5M HIPAA-compliant video encounters every month, VSee Health's highly scalable, customizable telehealth building blocks each meet stringent
security standards. VSee Health has deployed services in over 50 countries, including Iraq, Syria, Marshall Islands and El Salvador. Its
clients include NASA, US Department of Health and Human Services, McKesson, Magellan, DaVita, GE, countless startups, and the entire country
of Qatar. VSee Health also provides tailored solutions for critical shortage areas such as critical care and teleradiology. VSee Health
is committed to empowering high quality healthcare access and reducing physician burnout and workforce shortages through its telehealth
technology. For more information, please visit www.vseehealth.com.
About AbundaBox
AbundaBox is a pioneer in health and wellness,
dedicated to improving access to critical resources. From their groundbreaking AbundaLife platform to monthly HealthPacks that support
community health, AbundaBox, recognized by the White House and the CDC Foundation as a key partner in the Homeplate Solutions group, is
redefining health equity through innovation, affordability, and compassionate care. For more information, please visit: https://abundabox.com/.
Forward-Looking Statements
Matters discussed in this news release that are
not statements of historical or current facts, including but not limited to those relating to VSee Health's ability to improve healthcare
access and provider efficiencies, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform
Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance
or achievements to be materially different from historical results or from any future performance or achievements expressed or implied
by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information
on risk factors relating to VSee Health and its technology and billing services is included from time to time in the "Cautionary
Note Regarding Forward-Looking Statements," "Risk Factors" and "Management's Discussion and Analysis of Financial
Condition and Results of Operations" sections of VSee Health's periodic and current filings with the SEC, which are also made available
on VSee Health's website at www.vseehealth.com. Forward-looking statements speak only as of the date they are made, and VSee Health undertakes
no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise
that occur after that date, or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.
Contact:
Dave Gentry, CEO
RedChip Companies, Inc.
1-407-644-4256
VSEE@redchip.com
v3.24.3
Cover
|
Dec. 06, 2024 |
Document Type |
8-K
|
Amendment Flag |
false
|
Document Period End Date |
Dec. 06, 2024
|
Entity File Number |
001-41015
|
Entity Registrant Name |
VSEE
HEALTH, INC.
|
Entity Central Index Key |
0001864531
|
Entity Tax Identification Number |
86-2970927
|
Entity Incorporation, State or Country Code |
DE
|
Entity Address, Address Line One |
980 N Federal Hwy #304
|
Entity Address, City or Town |
Boca Raton
|
Entity Address, State or Province |
FL
|
Entity Address, Postal Zip Code |
33432
|
City Area Code |
561
|
Local Phone Number |
672-7068
|
Written Communications |
false
|
Soliciting Material |
false
|
Pre-commencement Tender Offer |
false
|
Pre-commencement Issuer Tender Offer |
false
|
Entity Emerging Growth Company |
true
|
Elected Not To Use the Extended Transition Period |
false
|
Common Stock [Member] |
|
Title of 12(b) Security |
Common Stock, $0.0001 par value per share
|
Trading Symbol |
VSEE
|
Security Exchange Name |
NASDAQ
|
Warrant [Member] |
|
Title of 12(b) Security |
Warrants,
which entitles the holder to purchase one (1) share of common stock at a price of $11.50 per whole share
|
Trading Symbol |
VSEEW
|
Security Exchange Name |
NASDAQ
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
Grafico Azioni VSee Health (NASDAQ:VSEEW)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni VSee Health (NASDAQ:VSEEW)
Storico
Da Dic 2023 a Dic 2024